R57 I25
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Written declaration of consent by the study participant - Age >18 years - Elective cardiac surgery using a cardiopulmonary bypass (heart-lung machine)
Exclusion criteria
Exclusion criteria: - Age < 18 years - Refusal to participate in studies - Known pregnancy - Dark skin type (methodological limitation for cutaneous hyperspectral imaging) - Emergency intervention - Aortic surgery (micro- and macrocirculation often already influenced by the disease itself) - Presence of Extracorporeal Life Support (ECLS) systems assuming hemodynamic functions (vv/vaECMO, Impella, IABP, LVAD) at the time of inclusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes are the correlation of the HSI parameters with the vasoactive-inotropic score (VIS). The VIS quantifies the amount of cardiovascular support and includes the active substances dopamine, dobutamine, epinephrine, milrinon, vasopressin and norepinephrine. The primary outcome parameters are the correlations between the HSI parameters (StO2, NIR or NPI, THI and TWI) after a VOT induced PORH as expression of the cutaneous MRF and the VIS. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are derived from the secondary goals and include the care data collected as part of standard anaesthesiological therapy. | — |
Countries
Germany
Contacts
Universitätsklinikum Essen Klinik für Anästhesiologie und Intensivmedizin